Prevention of hepatitis B infections by passive immunization.
Experience with the use of standard immune serum globulin (ISG) and the more recently available hepatitis B immune globulin (HBIG) is reviewed. The biologic phenomena which could be affected by passive immunization are discussed, as are recommendations for the use of these forms of passive immunization in the prevention of hepatitis B infections.
D000328:Adult; D006509:Hepatitis B / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000008:administration & dosage; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D012306:Risk; D065227:Transfusion Reaction
D006510:Hepatitis B Antibodies; D007106:Immune Sera